DiaMedica Therapeutics
DiaMedica Therapeutics

DiaMedica Therapeutics

Measured by AhrefsDR35Ahrefs DR: 35/100. Below median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent47Agent Readiness: 47/100. Above median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed62Site Speed: 62/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust90Data Trust: 90/100. Top 25%. Measured by StartupHub.ai. Median 61.

Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases.

2000ActiveMinneapolis, United States

About

DiaMedica Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies that reduce ischemia for patients with serious vascular diseases. Their initial focus is on preeclampsia, fetal growth restriction, and acute ischemic stroke, aiming to reverse ischemic injury and improve patient outcomes. The company is advancing patient care through a novel approach with their lead drug candidate, DM199.

Key facts

Website
diamedica.com
Headquarters
Minneapolis, United States
Founded
2000
Total funding
$30M (Private Placement)
Business model
B2B

Funding rounds

Funding rounds raised by DiaMedica Therapeutics
DateRoundAmountLead investors
21 Jul 2025Private Placement$30M

Tech stack

Detected on diamedica.com, last scanned 22 Sept 2026.

Frontend
Bootstrap
Analytics
Google Analytics 4
Hosting
AWS

DiaMedica Therapeutics scores 35. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is DiaMedica Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for DiaMedica Therapeutics is 90 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has DiaMedica Therapeutics raised?

DiaMedica Therapeutics has raised a total of $30M in funding. The most recent round on record is Private Placement.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for DiaMedica Therapeutics